Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Lobbying Update: $10,000 of SI-BONE INC. lobbying was just disclosed

None

$10,000 of SI-BONE INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"issues related to the medical device industry and incentivizing new technology issues related to reimbursement for implantable medical devices"

You can find more data on corporate lobbying on Quiver Quantitative.

SIBN Insider Trading Activity

SIBN Insider Trades

SIBN insiders have traded $SIBN stock on the open market 50 times in the past 6 months. Of those trades, 0 have been purchases and 50 have been sales.

Here’s a breakdown of recent trading of $SIBN stock by insiders over the last 6 months:

  • JEFFREY W DUNN has made 0 purchases and 6 sales selling 100,586 shares for an estimated $1,912,022.
  • ANSHUL MAHESHWARI (Chief Financial Officer) has made 0 purchases and 13 sales selling 37,904 shares for an estimated $711,142.
  • MICHAEL A. PISETSKY (SVP, Ops & Adm/Chief Legal Ofr) has made 0 purchases and 12 sales selling 33,245 shares for an estimated $625,395.
  • LAURA FRANCIS (Chief Executive Officer) has made 0 purchases and 10 sales selling 33,506 shares for an estimated $562,631.
  • ANTHONY J RECUPERO (President, Commercial Ops) has made 0 purchases and 8 sales selling 14,654 shares for an estimated $246,048.
  • JOHN GORDON FREUND sold 12,132 shares for an estimated $193,997

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

SIBN Hedge Fund Activity

We have seen 88 institutional investors add shares of SIBN stock to their portfolio, and 82 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SIBN Analyst Ratings

Wall Street analysts have issued reports on $SIBN in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Truist Securities issued a "Buy" rating on 12/18/2025
  • Needham issued a "Buy" rating on 12/16/2025
  • Cantor Fitzgerald issued a "Overweight" rating on 08/05/2025

To track analyst ratings and price targets for SIBN, check out Quiver Quantitative's $SIBN forecast page.

SIBN Price Targets

Multiple analysts have issued price targets for $SIBN recently. We have seen 5 analysts offer price targets for $SIBN in the last 6 months, with a median target of $25.0.

Here are some recent targets:

  • David Rescott from Truist Securities set a target price of $23.0 on 12/18/2025
  • Caitlin Roberts from Canaccord Genuity set a target price of $27.0 on 12/17/2025
  • David Saxon from Needham set a target price of $27.0 on 12/16/2025
  • Drew Ranieri from Morgan Stanley set a target price of $23.0 on 12/02/2025
  • Ross Osborn from Cantor Fitzgerald set a target price of $25.0 on 08/05/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles